Last filing: Jun 15, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Halozyme Therapeutics, Inc. (HALO) | SVP, Chief Legal Officer | Jan 5, 2022 | Jun 15, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 12, 2026, Halozyme Therapeutics, Inc.: 5,034 shares vested; 2,715 shares withheld by the company for taxes. 1 filing: 1
- Feb 23, 2026, Halozyme Therapeutics, Inc.: 7,011 shares vested; 3,782 shares withheld by the company for taxes. 1 filing: 1
- Feb 20, 2026, Halozyme Therapeutics, Inc.: 5,332 shares vested; 2,876 shares withheld by the company for taxes. 1 filing: 1
- Feb 16, 2026, Halozyme Therapeutics, Inc.: 16,812 shares vested; 9,068 shares withheld by the company for taxes. 1 filing: 1
- Jan 3, 2026, Halozyme Therapeutics, Inc.: 7,611 shares vested; 4,243 shares withheld by the company for taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.